找到约 18 条 “HA14-1” 相关结果 (用时 0.11 秒)
目录号 | 产品名称 | 中文名称 | 靶点 |
---|---|---|---|
M3753 | HA14-1 | HA14-1 | Bcl-2 |
HA14-1是非肽类Bcl-2表面口袋配体,IC50为9 μM。 | |||
M11696 | ChemBridge-5141477 | ChemBridge化合物-5141477 | Screening Compounds and Building Blocks |
1-(2,4-dihydroxy-5-methylphenyl)-2-(4-methylphenoxy)ethanone (5141477) | |||
ChemBridge特有类药化合物/先导化合物-5141477,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M13208 | ChemBridge-9141112 | ChemBridge化合物-9141112 | Screening Compounds and Building Blocks |
N-[3-(3,4-dihydro-2(1H)-isoquinolinylcarbonyl)phenyl]methanesulfonamide (9141112) | |||
ChemBridge特有类药化合物/先导化合物-9141112,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M17955 | (13alpha,14beta,17alpha,20S)-5alpha-Lanosta-8,24-Dien-3beta-Ol | 表大戟二烯醇 | Others |
Tirucallol 是一种从 Euphorbia lacteal 乳胶中分离得到的四环三萜。 | |||
M46315 | ChemBridge-7814155 | ChemBridge化合物-7814155 | Screening Compounds and Building Blocks |
methyl 2-{[(1,2,3,4-tetrahydro-1-naphthalenylamino)carbonyl]amino}benzoate hydrochloride (7814155) | |||
ChemBridge特有类药化合物/先导化合物-7814155,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46972 | ChemBridge-9146011 | ChemBridge化合物-9146011 | Screening Compounds and Building Blocks |
2-[(2-{[(9-ethyl-9H-carbazol-3-yl)methyl]amino}ethyl)amino]ethanol dihydrochloride (9146011) | |||
ChemBridge特有类药化合物/先导化合物-9146011,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46976 | ChemBridge-9148410 | ChemBridge化合物-9148410 | Screening Compounds and Building Blocks |
2-[4-(2-methyl-3,5-diphenylpyrazolo[1,5-a]pyrimidin-7-yl)-1-piperazinyl]ethanol (9148410) | |||
ChemBridge特有类药化合物/先导化合物-9148410,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48891 | ChemBridge-78141181 | ChemBridge化合物-78141181 | Screening Compounds and Building Blocks |
[(1S*,3S*,3aS*,6aR*)-5-benzyl-3-(1-methyl-1H-imidazol-5-yl)-1-phenyloctahydropyrrolo[3,4-c]pyrrol-1-yl]methanol (78141181) | |||
ChemBridge特有类药化合物/先导化合物-78141181,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M9347 | ITI-214 phosphate | ITI-214 phosphate | PDE |
ITI214 | |||
ITI-214 phosphate是一种具有口服活性的、强效和选择性的PDE1抑制剂,表现出强效的PDE1抑制活性 (Ki = 58 pM)。ITI-214 分别以 33 pM、380 pM 和 35 pM 的Ki 抑制重组人 PDE1A、PDE1B 和 PDE1C。 | |||
M6222 | Adalimumab | 阿达木单抗 | TNF Receptor |
LU200134, D2E7, Anti-Human TNF-alpha | |||
Adalimumab是靶向TNF-alpha的人源重组单克隆抗体,抑制TNF-alpha,可用于骨关节炎(OA)和炎症性肠病(IBD)的相关研究。MW: 144.19 KD。(适用于人源及非人源化小鼠) | |||
M7180 | QX 314 bromide | QX 314 bromide | Sodium Channel |
QX-314 bromide | |||
QX 314 bromide是lidocaine的一种膜不渗透四元衍生物,同时也是电压激活 Na+通道(Sodium Channel)的阻断剂。此外,在细胞内 QX 314 还能抑制海马 CA1 锥体神经元的钙电流。 | |||
M8835 | UA62784 | UA62784 | Others |
Studies have also reported that UA62784 associates with tubulin at or near the colchicine-binding sites in cells and functions as a cytotoxic, microtubule inhibitor. | |||
M10771 | (R)-GNE-140 | (R)-GNE-140 | LDH |
(R)-GNE-140是选择性的LDHA 和 LDHB抑制剂,IC50分别为3 nM和5 nM。(R)-GNE-140的效力是其S型异构体的18倍。 | |||
M21079 | Loxoprofenol-SRS tromethamine | Loxoprofenol-SRS tromethamine | COX |
HR1405–01 | |||
Loxoprofenol-SRS tromethamine(HR1405–01)是一种具有炎症和镇痛活性的静脉注射NSAID,具有良好的抗炎和镇痛活性。 | |||
M28805 | PU141 | PU141 | Histone Acetyltransferase |
PU141 是一种选择性的 HAT 抑制剂。PU141 选择性作用于 CBP 和 p300。PU141 可诱导细胞组蛋白低乙酰化并抑制多种肿瘤细胞系生长。具有抗肿瘤活性。 | |||
M31115 | Recombinant Mouse CD28 (Mammalian, C-Fc-6His) | 重组小鼠CD28蛋白 (C-Fc-6His) | Recombinant Proteins |
CD28 is one of the proteins expressed on T cells that provide co-stimulatory signals, which are required for their activation. It is the receptor for CD80 and CD86. Recombinant Mouse CD28 is produced by Mammalian expression system and the target gene encoding Asn20-Lys149 is expressed with a human IgG1 Fc, 6His tag at the C-terminus. | |||
M43004 | Cisplatin-resistant cells-IN-1 | Cisplatin-resistant cells-IN-1 | Others |
Cisplatin-resistant cells-IN-1 has high cytotoxicity against Cisplatin-resistant cells. Cisplatin-resistant cells-IN-1 reduces the metabolic activity effectively in the low nanomolar range (IC50: 0.14–1.79 μM in A549/A549-R, K562/K562-R, and MCF-7/MCF-7Ta䲧皢Ỵ皣 㧀皡 | |||
M49403 | Relutrigine | Relutrigine | Sodium Channel |
PRAX-562 | |||
Relutrigine是一种具有口服活性的持久性钠通道 (sodium channel) 抑制剂,能有效且优先抑制 ATX-II (Nav 1.5 激活剂) 或 SCN8A 突变 N1768D 诱导的持续性 INa,IC50 值分别为 141 nM 和 75 nM。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号